Tinea Manuum In Immunocompromised Patients: Special Considerations For Treatment
Published on: June 26, 2025
Tinea Manuum In Immunocompromised Patients: Special Considerations For Treatment
  • Article author photo

    Luca Omotaje

    Pharmacovigilance Professional | Medical Writer | Certified CTA | Data Analytics (NCFE Level 3)

Introduction - What is tinea manuum?

Tinea manuum is a fungal infection that affects the outer layer of skin on one or both hands, especially the palms and spaces between the fingers.1 It is commonly caused by dermatophytes2 and can result in redness, itching, and peeling or scaling of the skin.1 There are also reports of rare cases caused by the fungi, Hendersonula toruloidea and Scytalidium hyalinum.2 The infection is often spread through direct contact with contaminated surfaces or infected individuals. 

What does it mean for a patient to be immunocompromised?

A patient is considered immunocompromised when their immune system is weakened, reducing their ability to defend against infections and diseases, including viruses, bacteria, cancer, and fungal infections.

The ability of an immunocompromised patient to respond to infections or injuries is significantly reduced due to underlying diseases or medical treatments.3 In recent decades, the number of critically ill immunocompromised patients has risen sharply. These individuals are more vulnerable to various pathogens, including invasive fungi like Tinea manuum.4 Consequently, immunocompromised patients are at a higher risk of infections, making it crucial to focus on how Tinea manuum impacts this group.

Tinea manuum: A brief overview

How it spreads

Tinea manuum is a contagious fungal infection that spreads easily through both direct and indirect contact. Many cases begin with athlete’s foot (Tinea pedis), as the fungus can transfer from the feet to the hands through scratching or touching infected areas. This highlights why proper hygiene, such as washing hands after touching the feet, is essential in preventing its spread.

Tinea pedis and Tinea manuum are among the most common fungal infections, with Tinea pedis affecting up to 70% of adults.2 Beyond self-contamination, the infection can also spread through contact with infected individuals or animals, as well as exposure to contaminated surfaces like gym floors, towels, and shoes.1 Given how easily it spreads, early recognition and treatment are crucial to preventing further transmission.

Common causes

Tinea manuum is primarily caused by dermatophytes, a group of fungi that target the skin, hair, and nails. The most common culprit worldwide is Trichophyton rubrum, known for its prevalence in causing fungal infections. However, different regions may see other types of fungi responsible for the infection, including:

  • Trichophyton mentagrophytes
  • Epidermophyton floccosum
  • Trichophyton verruscum
  • Trichophyton interdigitale
  • Microsporum canis

Additionally, Tinea manuum can be caused by fungi like Hendersonula toruloidea, a less common pathogen linked to skin infections, and Scytalidium hyalinum, which is more likely to affect individuals in warmer climates. These fungi may not be as prevalent, but they contribute to the diversity of organisms responsible for skin infections in different environments.2

Recent studies have highlighted that infections caused by non-dermatophytes like Hendersonula toruloidea and Scytalidium hyalinum tend to result in significantly poorer outcomes compared to those caused by dermatophytes like Trichophyton rubrum.1 This suggests that while non-dermatophytes may be less common, their infections are often more challenging to treat and manage.

Why immunocompromised people are at higher risk

Weakened immune system

People with weakened immune systems (immunocompromised) have bodies that struggle to fight germs like viruses, bacteria, and fungi. A healthy immune system acts like a shield, but when it's weak, infections can take hold more easily. This makes even common illnesses harder to overcome, as the body can't mount a strong defence.3

Increased risk of severe or persistent infections

For immunocompromised individuals, infections that are mild in healthy people can become prolonged, recurrent, or even life-threatening. Their weakened immune defences make it harder to fight off pathogens, increasing the risk of severe complications. For instance, fungal infections, typically harmless in those with a healthy immune system, can spread uncontrollably, posing significant health risks, particularly for high-risk groups such as ICU patients.4 In tropical regions like Southeast Asia, studies indicate that these infections are even more prevalent due to environmental conditions.5 Without a strong immune response, recovery is often delayed, and the likelihood of complications rises.3

Signs and symptoms of tinea manuum in immunocompromised patients

Common symptoms

Immunocompromised individuals are more susceptible to persistent and severe cases of Tinea manuum. Common symptoms include:

  • Persistent redness and irritation Lesions often appear between the fingers or on the palms, presenting as inflamed, red patches that fail to resolve on their own
  • Intense itching – The discomfort may worsen with heat, sweat, or stress, leading to persistent scratching that can further damage the skin2 
  • Scaling and cracking – The affected skin may become dry, rough, and flaky, sometimes developing painful fissures that make everyday tasks, such as washing hands or gripping objects, uncomfortable2 

More serious complications

If left untreated, Tinea manuum can progress beyond mild discomfort, leading to:

  • Spread of infection – The fungus can extend to the nails (onychomycosis) or other areas of the body, making treatment more challenging1
  • Painful skin damage – Cracks and fissures can develop, increasing sensitivity and causing pain when exposed to water, soap, or hand sanitisers4 
  • Long-term effects – Thickened, roughened skin and scarring may persist even after treatment, altering the skin’s texture and appearance4
  • Increased vulnerability to complications – For those with weakened immune systems, fungal infections can escalate quickly, sometimes leading to secondary bacterial infections or systemic involvement5

Special considerations for treating tinea manuum in immunocompromised patients

Treating Tinea manuum can be more challenging in individuals with weakened immune systems. These individuals may require stronger treatments, longer recovery times, and closer monitoring to prevent complications. Understanding the diagnostic process, available treatments, and the importance of early intervention can help in managing the condition effectively.

Diagnosis: identifying the infection

For immunocompromised individuals, a delayed diagnosis increases the risk of complications such as nail infections (onychomycosis) or deeper skin involvement.4,5 How do doctors identify the specific infection? There are several methods used by clinicians to diagnose Tinea manuum:

  • Visual Examination – The infection typically presents as scaly, red patches with raised edges, often affecting only one hand6
  • Skin Scrapings (KOH Test) – A small skin sample is treated with potassium hydroxide (KOH) to detect fungal elements under a microscope. This test has an 80% accuracy rate2,6
  • Fungal Culture – If the infection is severe or does not respond to treatment, a fungal culture can confirm the exact cause, though results take 2-4 weeks4 

Common treatments

The most appropriate treatment option depends on the severity of the infection identified.

Mild Cases: Topical Antifungals

Over-the-counter creams such as clotrimazole, miconazole, and terbinafine are the first line of treatment. These should be applied twice daily for at least 4-6 weeks.2 In immunocompromised individuals, healing may take longer, requiring extended treatment.6

Severe or Stubborn Cases: Oral Antifungals

If the infection persists or worsens, doctors may prescribe oral antifungal medications:

  • Terbinafine (250mg/day) – The most effective oral treatment, with a 70-80% cure rate1,6
  • Itraconazole – Used for resistant infections or cases involving non-dermatophyte fungi4 

While standard treatment lasts 4-6 weeks, immunocompromised patients may require 12-16 weeks to fully eliminate the infection.4 

Challenges to treatment in immunocompromised patients

Managing Tinea manuum in immunocompromised individuals presents unique challenges, often requiring early intervention, careful monitoring, and extended treatment durations to ensure effective recovery.

Individuals with weakened immune systems are more vulnerable to widespread infections, making prompt diagnosis and treatment essential.4,5 Without timely intervention, the infection can spread deeper into the skin or nails, increasing the risk of complications.3,6

Treatment options must also be adjusted based on the patient's overall health. While oral antifungal medications are often necessary for persistent infections, these drugs can affect liver and kidney function, requiring regular medical supervision.3,6 In some cases, topical treatments may be preferred to reduce the risk of side effects, though these may take longer to achieve full resolution.1,3

Additionally, standard treatment durations may not be sufficient. While most cases of Tinea manuum clear within 4-6 weeks, individuals with suppressed immune function often require an extended course of antifungal therapy lasting up to 12-16 weeks to fully eliminate the infection.4

By addressing these challenges with personalised treatment plans and ongoing medical oversight, healthcare providers can improve outcomes for immunocompromised patients affected by Tinea manuum.

Preventing tinea manuum infections

Hygiene and care tips

Maintaining good hand hygiene is essential in preventing Tinea manuum. Regular handwashing with soap and water helps remove fungal spores, while thorough drying between the fingers is equally important since moisture creates an ideal environment for fungal growth.6

Avoiding shared personal items such as towels, gloves, nail clippers, and sports equipment can help prevent the spread of infection. Fungal spores can remain on these objects and spread through direct contact.1,6 Individuals who wear gloves for extended periods, especially in occupational settings, should ensure they are clean, dry, and changed regularly, as prolonged exposure to moisture inside gloves can contribute to fungal overgrowth.2,6

Wearing breathable, moisture-wicking fabrics helps regulate skin conditions and prevents excessive sweating, further reducing the likelihood of infection.6 Taking these precautions can significantly lower the risk of developing Tinea manuum and limit its spread.

When to seek medical help

While mild cases of Tinea manuum often respond to over-the-counter antifungal treatments, some situations require medical attention. If symptoms persist or worsen despite two weeks of treatment, a stronger prescription antifungal may be necessary.4

Signs of secondary infection, such as increasing redness, swelling, pus formation, or systemic symptoms, indicate the need for medical evaluation since bacterial involvement may be present.3,4 If the infection spreads to the nails or other areas of the body, adjustments to the treatment plan may be required.2,6

Medical intervention is also recommended if the infection causes significant discomfort, pain, or skin fissuring that interferes with daily activities.3 Individuals with weakened immune systems need to be especially cautious, as early dermatological consultation can help prevent complications and improve treatment outcomes.4,5 Seeking timely medical care ensures the infection is managed effectively and reduces the risk of further complications.

Summary

Early detection and tailored treatment are essential for managing Tinea manuum in immunocompromised individuals. Weakened immune function increases the risk of persistent or severe infections, making timely diagnosis and targeted therapy crucial in preventing complications such as deeper skin involvement or systemic spread.4 Proactive medical management can help reduce the likelihood of prolonged infection and ensure better overall outcomes, particularly in high-risk individuals.5

Key takeaway

Tinea manuum can be effectively managed with proper antifungal treatment and preventive measures. However, individuals with weakened immune systems require additional precautions, including extended treatment durations,3 careful monitoring for potential drug interactions or side effects,4 and early medical intervention at the first signs of infection.6 By prioritising prompt care and ongoing medical oversight, even high-risk patients can achieve successful recovery while minimising complications.

References

  1. Suphatsathienkul P, Jirawattanadon P, Matthapan L, Prasong W, Panyawong C, Plengpanich A, et al. Tinea manuum: a 5 year retrospective study of demographic data, clinical characteristics, and treatment outcomes. Sci Rep 2025;15:3380. https://doi.org/10.1038/s41598-025-87011-w.
  2. Chamorro MJ, Syed HA, House SA. Tinea Manuum. StatPearls, Treasure Island (FL): StatPearls Publishing; 2025.
  3. Immunocompromised Patient - an overview | ScienceDirect Topics n.d. https://www.sciencedirect.com/topics/medicine-and-dentistry/immunocompromised-patient (accessed March 27, 2025).
  4. Garnacho-Montero J, Barrero-García I, León-Moya C. Fungal infections in immunocompromised critically ill patients. Journal of Intensive Medicine 2024;4:299–306. https://doi.org/10.1016/j.jointm.2024.01.005.
  5. Epidemiology and clinical implications of dermatophytes and nondermatophytes in South East Asia. Aspergillus and Aspergillosis n.d. https://www.aspergillus.org.uk/conference_abstracts/epidemiology-and-clinical-implications-of-dermatophytes-and-nondermatophytes-in-south-east-asia/ (accessed March 27, 2025).
  6. Society PCD. Tinea manuum (hands), pedis (feet), and unguium (nails). Primary Care Dermatology Society n.d. https://www.pcds.org.uk/clinical-guidance/tinea-pedis-feet-manuum-hands-and-unguium-nails (accessed March 27, 2025).
Share

Luca Omotaje

Pharmacovigilance Professional | Medical Writer | Certified CTA | Data Analytics (NCFE Level 3)
MSc Chemistry Research (with International Placement) - Keele University
BSc Pharmaceutical Chemistry - Manchester Metropolitan University

Luca is an experienced pharmacovigilance professional with over 9 years in drug safety, regulatory compliance, and scientific communication. As part of his professional development, he is currently contributing to Klarity Health, producing evidence-based medical content that bridges safety expertise with clear, accessible writing for patients and healthcare professionals. His long-term goal is to bridge content development with data integrity, support evidence-based decision-making, and promote regulatory excellence across medical writing and clinical data management.

arrow-right